• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用相同外用皮质类固醇治疗稳定期银屑病的两种治疗方案的比较。

Comparison of two therapeutic regimens using the same topical corticoid for stable psoriasis.

作者信息

Senter T P, Stimson D H, Charles G, Brand R J

出版信息

West J Med. 1983 Nov;139(5):657-62.

PMID:6362203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1010964/
Abstract

In a masked, randomized, concurrently controlled clinical trial we compared the therapeutic response of two regimens in which the same topical corticoid was used to treat 52 men who had stable psoriasis. One regimen, called reduced dose, consisted of once-a-day application of a representative potent fluorinated topical steroid ointment, fluocinonide (Lidex), combined with three-times-a-day application of its vehicle. The other regimen, called traditional dose, consisted of four-times-a-day topical application of the same steroid. Patients were assigned to one of the two regimens and observed for six weeks. Confidence intervals for the difference in true mean response under these two regimens provide good evidence that for these patients the traditional dose was not clinically superior to the reduced dose.

摘要

在一项双盲、随机、同期对照临床试验中,我们比较了两种治疗方案的疗效。这两种方案均使用同一种外用皮质类固醇治疗52例病情稳定的银屑病男性患者。一种方案称为减量方案,包括每日一次外用一种代表性的强效含氟外用类固醇软膏氟轻松(利德思),并联合每日三次外用其基质。另一种方案称为传统剂量方案,包括每日四次外用同一种类固醇。患者被分配至两种方案之一,并观察六周。这两种方案下真实平均反应差异的置信区间提供了充分证据,表明对于这些患者而言,传统剂量在临床上并不优于减量方案。

相似文献

1
Comparison of two therapeutic regimens using the same topical corticoid for stable psoriasis.使用相同外用皮质类固醇治疗稳定期银屑病的两种治疗方案的比较。
West J Med. 1983 Nov;139(5):657-62.
2
Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.0.25%地索奈德软膏与0.05%氟轻松软膏治疗银屑病的对比研究
Clin Ther. 1985;8(1):118-25.
3
Clobetasol propionate ointment once daily versus fluocinonide ointment three times daily in psoriasis.
Int J Dermatol. 1988 Jan-Feb;27(1):54-5. doi: 10.1111/j.1365-4362.1988.tb02340.x.
4
Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
Cutis. 1983 May;31(5):566-9.
5
Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.一项多中心研究,比较0.05%地索奈德凝胶制剂和氟轻松凝胶制剂治疗头皮银屑病患者的疗效。
Clin Ther. 1986;8(3):275-82.
6
Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study.
Cutis. 1982 Jun;29(6):646-50.
7
Fluocinonide compared with betamethasone in the treatment of eczema and psoriasis.
Practitioner. 1976 Jun;216(1296):704-6.
8
Clinical trial of a potent non-halogenated topical steroid, Budesonide.一种强效非卤化外用类固醇药物布地奈德的临床试验。
Acta Derm Venereol. 1981;61(2):180-2.
9
Preliminary clinical evaluation of a new topical corticosteroid, halopredone acetate, as compared to fluocinonide.
Arzneimittelforschung. 1977;27(12):2396-9.
10
Psoriasis: topical corticosteroid therapy.银屑病:外用皮质类固醇疗法。
Cutis. 1976 Jul;18(1):133, 136-7.

本文引用的文献

1
Are patients true to t.i.d. and q.i.d. doses?患者是否严格遵守每日三次和每日四次的服药剂量?
GP. 1954 Jun;9(6):66-9.
2
Applications of glucocorticosteroids. The effects of twice-daily vs once-every-other-day applications on mouse epidermal cell DNA synthesis.
Arch Dermatol. 1982 May;118(5):305-8. doi: 10.1001/archderm.118.5.305.
3
A comparison of single and multiple applications of halcinonide cream.卤米松乳膏单次及多次应用的比较。
Int J Dermatol. 1981 Nov;20(9):609-13. doi: 10.1111/j.1365-4362.1981.tb00847.x.
4
Use of glucocorticosteroids in psoriasis.
Pharmacol Ther. 1980;11(3):497-508. doi: 10.1016/0163-7258(80)90039-x.
5
Drug defaulting in a general practice.全科医疗中的药物漏服情况。
Br Med J. 1969 Jan 25;1(5638):218-22. doi: 10.1136/bmj.1.5638.218.
6
To be taken as directed.按指示服用。
J R Coll Gen Pract. 1968 Jul;16(1):39-44.
7
Bioassay system for formulations of topically applied glucocorticosteroids.局部应用糖皮质激素制剂的生物测定系统
Arch Dermatol. 1972 Dec;106(6):825-7.
8
"Metosyn" in psoriasis and eczema.“美卓乐”用于治疗银屑病和湿疹。
Br J Dermatol. 1972 Mar;86(3):310-1. doi: 10.1111/j.1365-2133.1972.tb02236.x.
9
Topical corticosteroids.外用皮质类固醇
Med Clin North Am. 1973 Sep;57(5):1253-64. doi: 10.1016/s0025-7125(16)32226-x.
10
Comparison of fluocinonide in a double-blind study with betamethasone valerate.
Curr Ther Res Clin Exp. 1972 Jan;14(1):35-8.